Who We Are
Orange Biomed is a healthcare startup with cutting-edge diabetes management technology.

Our Mission

Orange Biomed’s mission is to bring happiness to the daily lives of those with diabetes. By seamlessly integrating lab-level technology into point-of-care devices, we make healthcare more accessible and affordable for everyone.

Our Innovation

It’s not about improving the current technology. It's about disrupting the old-fashioned IVD method utilized for the last few decades.

Our Story

In 2019, our two co-presidents met at Duke University, one researching biomedical engineering at Duke Hospital and the other studying healthcare management at Duke Business School.​

The pandemic took over the U.S. in 2020. Our co-presidents worked to identify the unmet needs of patients having difficulty visiting a doctor to manage their diabetes due to isolation. This sparked the idea of a new technology and company.

In 2021, Orange Biomed was created to solve unmet diabetes-focused healthcare needs. How? By bringing state-of-the-art POC technology into patients' homes. Globally, 537 million people have diabetes. Monitoring HbA1c regularly is essential as it predicts a risk of developing life-threatening diabetic complications. 

In 2022, Orange Biomed successfully developed a prototype of a portable A1c meter. OBM rapid A1c is an accessible and affordable care option for proper diabetes management.

The home-based medical device fills the significant gap between hospitals and patients' homes by cutting healthcare costs and providing a better quality of life to people with diabetes.

In 2023 and beyond, Orange Biomed aims for OBM rapid A1c to become a game-changer in patient-oriented healthcare. OBM rapid A1c offers a user-centered design integrated with state-of-the-art technology.